Considering the differences in MPA incidence, survival and pathologic features, there should be a distinction between MPO-ANCA-positive and MPO-ANCA-negative patients with IIP, especially those with IPF. The gene discussed is MPO; the disease is idiopathic pulmonary fibrosis.